Lisdexamfetamine dimesylate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72205-134 -
Package NDC
72205-134-91 -
Application number
ANDA218306 -
SPL ID
a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811 -
SPL set ID
a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811 -
UNII
SJT761GEGS -
RxCUI
1871456 -
RxCUI
1871460 -
RxCUI
1871462 -
RxCUI
1871464 -
RxCUI
1871466 -
RxCUI
1871468
What the source publishes
- Labeler
- Novadoz Pharmaceuticals LLC
- Active ingredients
- Lisdexamfetamine dimesylate
- Form
- TABLET, CHEWABLE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lisdexamfetamine dimesylate",
"splId": "a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811",
"labels": [
{
"setId": "a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"
}
],
"routes": [
"ORAL"
],
"labeler": "Novadoz Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, CHEWABLE in 1 BOTTLE (72205-134-91)",
"package_ndc": "72205-134-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20240217"
}
],
"productId": "72205-134_a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811",
"useDomain": "unknown",
"dosageForm": "TABLET, CHEWABLE",
"productNdc": "72205-134",
"deaSchedule": "CII",
"genericName": "Lisdexamfetamine dimesylate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LISDEXAMFETAMINE DIMESYLATE",
"strength": "30 mg/1"
}
],
"applicationNumber": "ANDA218306",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240202",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0372205133914",
"0372205137912",
"0372205135918",
"0372205134911",
"0372205136915",
"0372205132917"
],
"unii": [
"SJT761GEGS"
],
"rxcui": [
"1871456",
"1871460",
"1871462",
"1871464",
"1871466",
"1871468"
],
"spl_set_id": [
"a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"
],
"manufacturer_name": [
"Novadoz Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72205-134_a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"